DIRS.INFO The most relevant business & tech news

☆ Oura CEO on new partnership with Dexcom
▼ + stars: | 2024-11-19 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailOura CEO on new partnership with DexcomTom Hale, Oura CEO, joins 'Squawk Box' to discuss the company's new partnership with Dexcom, glucose monitors, and much more.

Persons: Dexcom Tom Hale

☆ Stocks making the biggest moves premarket: Deckers Outdoor, Capital One, Capri, Skechers and more
▼ + stars: | 2024-10-25 | by ( Brian Evans | ) www.cnbc.com time to read: +4 min

Deckers posted earnings of $1.59 per share, topping the $1.24 a share expected from analysts polled by LSEG. Digital Realty also raised the top-end of its full-year revenue forecast to $5.6 billion, while analysts polled by FactSet expected $5.57 billion. The provision for credit losses came in at $2.48 billion, versus the $2.83 billion estimate from analysts polled by StreetAccount. Western Digital earned $1.78 per share, excluding items, while analysts polled by LSEG called for a profit of $1.72 per share. The company raised its full-year revenue outlook to $159 billion to $161 billion.

Persons: Hoka, FactSet, LSEG, ResMed, Wall, Skechers, Olin —, —, CNBC's Hakyung Kim, Sarah Min, Michelle Fox Organizations: LSEG, Revenue, Digital Realty Trust, Digital Realty, Capital, StreetAccount, Wall, FactSet, Western Digital, Joby Aviation, Olin, Olin — Stock, Colgate, Palmolive Locations: Capri

☆ Earnings growth is falling short of expectations thus far
▼ + stars: | 2024-10-24 | by ( Brian Evans | ) www.cnbc.com time to read: +2 min

Corporate earnings are not meeting expectations thus far. Roughly 160 S & P 500 companies have posted third-quarter results thus far, with their bottom lines growing an average of just 2.6%, per FactSet. The blended growth rate, which includes the reports already out and estimates for those on the docket, points to overall S & P 500 earnings growing at 3.4% from the year-earlier period. The S & P 500 rebounded slightly from a three-day slide on Thursday due in part to strong earnings reports. Companies slated to report earnings after the close Thursday include Deckers, Capital One and DexCom.

Persons: Joseph Cusick, " Cusick, Sam Stovall, Stovall Organizations: Calamos Investments, Research, Whirlpool, PayPal, CNBC, Companies, Tech, Amazon, Apple

☆ Dexcom shares fall on slow revenue growth
▼ + stars: | 2024-10-24 | by ( Ashley Capoot | In | ) www.cnbc.com time to read: +2 min

Shares of Dexcom fell 9% in extended trading on Thursday after the company released third-quarter results that beat analysts' expectations but showed a decline in U.S. revenue year over year. Here's how the company did:Earnings per share: 45 cents adjusted vs. 43 cents expected by LSEG45 cents adjusted vs. 43 cents expected by LSEG Revenue: $994 million vs. $990 million expected by LSEGThe company's revenue increased 2% to $994.2 million from $975 million a year earlier. The company maintained its full fiscal year guidance and expects revenue of $4 billion to $4.05 billion. Last quarter, Dexcom lowered its guidance from the $4.20 billion to $4.35 billion it forecast in the first quarter. This lowered guidance and a revenue miss caused Dexcom shares to tumble more than 40% following the release of its second-quarter results in July.

Persons: Dexcom, Kevin Sayer, Sayer, Teri Lawver, Lawver Organizations: LSEG Revenue, Dexcom

☆ Our software stocks jump, and industrial earnings teach an investment lesson
▼ + stars: | 2024-10-24 | by ( Jeff Marks | ) www.cnbc.com time to read: +4 min

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Dover CEO Richard Tobin discussed the dynamic on the company's third quarter earnings call earlier Thursday . As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, it's, Tesla, ServiceNow, Salesforce, Oppenheimer, Textron, It's, We're, Richard Tobin, Tobin, Edwards Lifesciences, Dexcom, Newell, Jim Cramer's, Jim Organizations: CNBC, ., Nasdaq, Dow Jones, Palo Alto Networks, Honeywell, Dover, Carrier Global, Aerospace, Union Pacific, United Parcel Service, Barclays, UPS, Federal Reserve, Boston Beer, Abbott Laboratories, Colgate, Palmolive, Centene, Newell Brands, New York Community Bancorp, Commerce Department, University of, Jim Cramer's Charitable Locations: Palo, Dover

☆ Stock futures are little changed after S&P 500 snaps 3-day losing streak: Live updates
▼ + stars: | 2024-10-24 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

S&P 500 futures are muted Thursday night after the broad index ended a three-day negative streak. Futures tied to the broad index added less than 0.1%, as did Nasdaq 100 futures . The Nasdaq Composite joined the S&P 500 in finishing the session in the green, with both lifted by Tesla' s post-earnings rally. A slide in Treasury yields also gave the S&P 500 and Nasdaq upward momentum, according to Megan Horneman, chief investment officer at Verdence. The Dow has fared the worst with a drop of more than 2% as of Thursday's close, while the S&P 500 and Nasdaq have shed 0.9% and 0.4%, respectively.

Persons: Dexcom, Tesla, Elon, Megan Horneman, Horneman, Dow, They'll Organizations: New York Stock Exchange, Dow Jones Industrial, Nasdaq, Treasury, IBM, Boeing, Colgate, Palmolive, AutoNation, Newell Brands, University of

☆ Stocks making the biggest moves after hours: Dexcom, Capri, Skechers, Capital One and more
▼ + stars: | 2024-10-24 | by ( Alex Harring | ) www.cnbc.com time to read: +3 min

Dexcom — Shares slid nearly 7%, despite the manufacturer of diabetes management devices posting a third-quarter adjusted earnings and revenue beat. L3Harris reported adjusted earnings of $3.34 per share on revenue of $5.29 billion, while analysts polled by LSEG had expected $3.26 per share on $5.28 billion in revenue. Boyd reported adjusted earnings of $1.52 a share, beating the consensus estimate of analysts polled by FactSet by 12 cents. In the third quarter, Capital One reported adjusted earnings of $4.51 per share on revenue of $10.01 billion. The company's provision for credit losses came in at $2.48 billion, versus the $2.83 billion estimate from analysts polled by StreetAccount.

Persons: Dexcom, LSEG, Kate Spade, Gucci, Michael Kors, Jimmy Choo, FactSet, Morgan Stanley, Skechers, Boyd, Darla Mercado, Lisa Kailai Han, Christina Cheddar Berk Organizations: Technologies, Tapestry, LSEG, Kinsale Capital, Kinsale, Joby Aviation, Allen, Co, FactSet, Boyd, Revenue, StreetAccount Locations: Kinsale

☆ Cramer's Lightning Round: Cheniere Energy is a buy
▼ + stars: | 2024-10-21 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

Stock Chart Icon Stock chart icon Cheniere Energy's year-to-date stock performance. Stock Chart Icon Stock chart icon IonQ's year-to-date stock performance. Stock Chart Icon Stock chart icon NuScale Power's year-to-date stock performance. Stock Chart Icon Stock chart icon AST SpaceMobile's year-to-date stock performance. Stock Chart Icon Stock chart icon Dexcom's year-to-date stock performance.

Persons: Cheniere, NuScale Organizations: Cheniere, GE, GE Vernova

☆ Lightning Round: AST SpaceMobile is overvalued, says Jim Cramer
▼ + stars: | 2024-10-21 | by ( Jim Cramer | ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLightning Round: AST SpaceMobile is overvalued, says Jim Cramer'Mad Money' host Jim Cramer weighs in on stock including: Cheniere, GE Vernova, HubSpot, IONQ, Sportradar, Nuscale Power, Vistra, and Dexcom.

Persons: Jim Cramer Organizations: GE Vernova

☆ Here are the 5 things that could move the stock market in the week ahead
▼ + stars: | 2024-10-20 | by ( Zev Fima | ) www.cnbc.com time to read: +10 min

Earnings drove the stock market higher — can they do it again in the week ahead? But he acknowledged that timing is key because our portfolio discipline mandates that we consider lightening up our stock exposure in an overbought market. In fact, AMD was our worst-performing stock for the entire week, losing more than 7% following the prior week's 1.8% slide. Energy was the worst sector of the week for the market as oil prices sank. In the week ahead, housing numbers are the main draw on the economic front.

Persons: Jim Cramer, ASML, Morgan Stanley, WTI, industrials, We're, Sartorius, Danaher, we're, Stanley Black, Lockheed Martin, Philip Morris, Clark, Baker Hughes, Lam, DOV, CARR, Davidson, Northrop, Edwards Lifesciences, Jim Cramer's, Jim, Stocks, Tuesday's, Spencer Platt Organizations: Dow, Nasdaq, Netflix, Modelo, Corona, Constellation Brands, Taiwan Semiconductor Manufacturing Company, Nvidia, AMD, Broadcom, Club, Abbott Laboratories, Energy, Texas, Honeywell, Danaher, Federal Reserve, Treasury, SAP, Logitech, Verizon, General Motors, GE Aerospace, GE, Lockheed, Quest Diagnostics, Norfolk Southern, Polaris, Seagate Technology, Texas Instruments, Canadian National Railway Company, Boeing, GE Vernova, Fisher, Boston, General Dynamics, Hilton, Lam Research, Business Machines, IBM, Newmont, Viking Therapeutics, Vista Energy, Mattel, O'Reilly Automotive, Whirlpool, American Airlines, United Parcel Service, Southwest Airlines, Tractor Supply Company, Carrier Global, Dow Chemical, DOW, Harley, Union Pacific, Valero Energy, Hasbro, Northrop Grumman, Ryder, Boyd Gaming, Western, Boston Beer Company, York Community Bancorp, Colgate, Palmolive, Newell Brands, Jim Cramer's Charitable, CNBC, NEW, Traders, New York Stock Exchange, Getty Locations: BlackRock, CrowdStrike, U.S, Dover, Freeport, McMoRan, Kimberly, Norfolk, Las, ORLY, VALE, New York City

☆ Embattled Abbott Labs comes through with a strong quarter, buyback announcement
▼ + stars: | 2024-10-16 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +9 min

Organic sales, which exclude Covid testing, were up 8.2% from the year-ago period. Bottom line In its third quarter, Abbott Labs demonstrated why we wanted to stick with the stock in the face of legal battles that emerged earlier this year and spooked investors. "There's just a lot to like with the Abbott quarter." As Abbott's organic sales growth continues to shine, the market will realize both concerns are overblown. The company reiterated its full-year organic sales growth outlook of 9.5% to 10%.

Persons: ABT, Abbott, Jim Cramer, Dexcom, Robert Ford, Ford, Lingo, —, it's, Edwards, Jim Cramer's, Jim, Ethan Miller Organizations: Abbott Laboratories, Revenue, Abbott Labs, NEC, Abbott, Ford, and Drug Administration, Centers for Disease Control, National Institutes of Health, CNBC, Las Vegas Convention, Getty Locations: U.S, Missouri, Las Vegas , Nevada

☆ Abbott launches its first over-the-counter continuous glucose monitor in the U.S.
▼ + stars: | 2024-09-05 | by ( Ashley Capoot | In | ) www.cnbc.com time to read: +3 min

Abbott Laboratories announced Thursday its over-the-counter continuous glucose monitor Lingo is available in the U.S. starting at $49. These devices, called continuous glucose monitors, are small sensors that stick through the skin to measure real-time glucose levels. Continuous glucose monitors have served as tools for patients with diabetes, but Lingo is not intended for diabetes management. The company released its over-the-counter continuous glucose monitor geared toward this demographic in late August. The U.S. Food and Drug Administration approved Dexcom's Stelo in March, and it cleared two over-the-counter continuous glucose monitoring systems from Abbott in June.

Persons: Lingo, it's, Abbott, That's, Ben Fohner, Abbott's, Olivier Ropars, Ropars, Dexcom's Organizations: Abbott, CNBC, U.S . Food, Drug Administration, Dexcom's Stelo, Libre, Libre Rio Locations: U.S

☆ Cramer's Lightning Round: Lowe's is a buy
▼ + stars: | 2024-07-30 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

Stock Chart Icon Stock chart icon Borr Drilling's year-to-date stock performance. Stock Chart Icon Stock chart icon Blackstone's year-to-date stock performance. Stock Chart Icon Stock chart icon Dexcom's year-to-date stock performance. Stock Chart Icon Stock chart icon Lowe's year-to-date stock performance. Stock Chart Icon Stock chart icon Joby Aviation's year-to-date stock performance.

Persons: Borr, Blackstone, Abbott, Edwards Lifesciences, Edwards, Joby, Marvell, Matt Murphy, Jim Cramer's Organizations: Borr, Boston Scientific, Joby, Marvell Technology, Marvell

☆ Lightning Round: You should buy Lowe's right here, right now, says Jim Cramer
▼ + stars: | 2024-07-30 | by ( Jim Cramer | ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLightning Round: You should buy Lowe's right here, right now, says Jim CramerMad Money' host Jim Cramer weighs in on stock including: Borr Drilling, Blackstone, Dexcom, Edwards Lifesciences, Lowe's, Joby, and Marvell.

Persons: Jim Cramer Mad, Jim Cramer, Dexcom, Edwards Organizations: Blackstone, Marvell

☆ Stocks making the biggest moves midday: Walt Disney, Dexcom, McDonald's, On Semiconductor and more
▼ + stars: | 2024-07-29 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +2 min

Revvity — The life sciences company advanced 6% after posting a second-quarter earnings beat. Revvity's adjusted earnings of $1.22 per share topped the FactSet estimate of $1.12 per share. The new Marvel movie topped $200 million at the domestic box office, a record opening weekend for an R-rated film. Second-quarter adjusted earnings per share came in at 96 cents, versus the expected consensus estimate of 92 cents, per FactSet. The stock plunged more than 40% in the previous session after Dexcom reported disappointing second-quarter results and offered weak guidance.

Persons: Tesla, Morgan Stanley, Adam Jonas, Walt Disney, Dexcom, — CNBC's Sean Conlon, Michelle Fox, Alex Harring, Jesse Pound, Samantha Subin Organizations: Management, Guggenheim, Ford, Deutsche Bank, Walt Disney —, Marvel, Semiconductor —, Revenue, Dexcom, Health Canada

☆ Investors are punishing stocks that miss earnings more than normal this season
▼ + stars: | 2024-07-29 | by ( Yun Li | ) www.cnbc.com time to read: +2 min

Companies with disappointing quarterly results are getting punished more than usual this earnings season. This phenomenon underscores the high expectations going into this season as well as a stock market that's viewed by many as overheated. Case in point, shares of Ford Motors plunged more than 18% on Thursday after the automaker came in short of earnings expectations due to warranty costs. "So far this earnings season, the results for many large bellwether companies have been better than the stock reactions," John Belton, portfolio manager at Gabelli Funds, said in an email. Investors will be closely watching this week's earnings slate , which includes Microsoft , Meta Platforms , Apple and Amazon .

Persons: FactSet, Peter Boockvar, Dexcom, John Belton Organizations: Bleakley Financial, CNBC, Ford Motors, JPMorgan Chase, Gabelli, Microsoft, Meta, Apple

☆ Stock market today: Dow soars 654 points as traders celebrate inflation data
▼ + stars: | 2024-07-26 | by ( Filip De Mott | ) www.businessinsider.com time to read: +3 min

Encouraging inflation data stoked optimism that the Federal Reserve can cut interest rates in September. That changed Friday, as encouraging inflation data injected new life into the rally. Advertisement"Next week we expect [Fed Chair Jerome] Powell to set the table for future rate cuts, speaking confidently about progress bringing inflation down. According to the CME FedWatch Tool, the market no longer expects the Federal Reserve to keep rates steady in September. The market also forecasts high chances that the Fed will slash rates by up to 75 basis points through December.

Persons: Russell, —, Jerome, Powell, David Donabedian, Chris Zaccarelli, Dexcom Organizations: Federal, Service, PCE, CIBC Private Wealth, Reserve, Independent, Alliance Locations: Here's, –

☆ WEX Wrap-Up: Dexcom shares tumble on lowered guidance
▼ + stars: | 2024-07-26 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWEX Wrap-Up: Dexcom shares tumble on lowered guidanceCNBC's Frank Holland digs into the top stories in the markets today.

Persons: CNBC's Frank Holland

☆ Disney is among the most oversold stocks on Wall Street. Here are the others
▼ + stars: | 2024-07-26 | by ( Pia Singh | ) www.cnbc.com time to read: +4 min

Several companies appear oversold this week and could be due for a rebound after a wild week on Wall Street. Stocks with a 14-day RSI reading below 30 often indicate that it's oversold, with a potential rebound possible ahead for the company's shares. Here are some of the most oversold names: Dexcom is the most oversold stock of the list, with a 14-day RSI of 11.6%. Wells Fargo recently reiterated its overweight rating on Disney and its $136 price target, which implies shares could gain 52.4%. That's driven the stock's RSI to more than 81.

Persons: —, Walt Disney, Wells Fargo, we're, Steven Cahall, Wall, Sara Senatore, Senatore, FactSet, LSEG, Myers Squibb, Northrop Organizations: Nasdaq, CNBC, Stock, Entertainment, Walt, Disney, DIS, Media, " Bank of America, Mohawk Industries, RSI, Northrop Grumman, Citizens Financial Group Locations: Bristol

☆ Dexcom stock plummeting is an 'opportunity to add to positions', says Wolfe Research's Mike Polark
▼ + stars: | 2024-07-26 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDexcom stock plummeting is an 'opportunity to add to positions', says Wolfe Research's Mike PolarkMike Polark, Wolfe Research, joins 'Closing Bell Overtime' to talk Dexcom shares plummeting on Q2 results and how to play the stock.

Persons: Wolfe, Mike Polark Mike Polark Organizations: Wolfe Research

☆ An ugly earnings report from a competitor is good news for Abbott Labs
▼ + stars: | 2024-07-26 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +3 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. In the wreckage of Dexcom 's second-quarter earnings report, there's good news for Club holding Abbott Laboratories . As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Stocks, Stanley Black, Decker, Abbott, Dexcom, salesforce, Jim Cramer's, ABT, DOV, Jim Organizations: CNBC, Dow Jones, Nasdaq, Federal, U.S, Club, Abbott Laboratories, Dover, Mizuho Securities Locations: Dover

☆ Dexcom shares plunge more than 40%, head for worst day on record
▼ + stars: | 2024-07-26 | by ( Ashley Capoot | In | ) www.cnbc.com time to read: +4 min

Dexcom shares sank more than 40% on Friday and headed for their worst day ever after the diabetes management company reported disappointing revenue for the second quarter and offered weak guidance. The stock fell $45.38 to $62.47 as of early afternoon, wiping out about $18 billion in market cap. Prior to Friday, the biggest drop came in September 2017, when the shares plunged 33% in a day. Dexcom held its stock market debut in 2005. With Friday's selloff, Dexcom shares are down almost 50% for the year, while the S&P 500 is up 15%.

Persons: Dexcom, Kevin Sayer, we've, Sayer, JPMorgan's Robbie Marcus, Marcus, Jereme Sylvain, Sylvain, William Blair, Leerink, Stelo, Friday's Organizations: JPMorgan, U.S . Food, Drug Administration

☆ 10 things to watch in the stock market Friday after a tumultuous week
▼ + stars: | 2024-07-26 | by ( Jeff Marks | ) www.cnbc.com time to read: +3 min

The data didn't sway the market odds on the Fed cutting interest rates three times this year, starting in September. The industrial conglomerate raised its full-year outlook. Two of the Club's industrial names, Honeywell and Dover , reported earnings this week with mixed fortunes for their stocks. Dexcom shares plunged more than 35% after the medical device company missed on revenue and cut its full-year outlook. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Bristol Myers, Abbott, Skechers, Lockheed Martin, L3Harris, Japan's Eisai, Eli Lilly, Jim Cramer's, Jim Cramer, Jim Organizations: Nasdaq, Federal, Transportation, Electronics, Honeywell, Colgate, Palmolive, Abbott Laboratories, Libre, Deutsche Bank, Lockheed, EU, Novo Nordisk, Jim Cramer's Charitable, CNBC Locations: Dover

☆ Stocks making the biggest moves premarket: Coursera, WW International, DexCom, Deckers and more
▼ + stars: | 2024-07-26 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +3 min

Dexcom — The medical device stock plummeted more than 36% after the company posted a second-quarter revenue miss. The company's $579 million revenue was also lower than the consensus estimate of $597 million. Coursera — The online course provider stock surged 26% after Coursera posted second-quarter revenue of $170 million, which exceeded the $164 million analysts had expected, according to LSEG. 3M — The industrials giant added nearly 7% after posting second-quarter adjusted earnings of $1.93 and adjusted revenue of $6.02 billion. Charter's $13.69 billion revenue also exceeded the $13.59 billion analysts had expected.

Persons: George Kurtz, LSEG, Dexcom, Boston Beer, Coursera, Bristol Myers, Morgan Stanley, —, Alex Harring, Sarah Min, Jesse Pound Organizations: Semiconductor, Nvidia, Broadcom, Devices, Qualcomm, Micron Technology, Boston Beer, Boston, Mohawk Industries, Mohawk, Bristol Myers Squibb, Bristol, Revenue, Norfolk Southern, Charter Communications

☆ Stocks making the biggest moves midday: 3M, Dexcom, Sweetgreen, Texas Roadhouse and more
▼ + stars: | 2024-07-26 | by ( Alex Harring | ) www.cnbc.com time to read: +6 min

Dexcom — Shares plummeted more than 40% after the medical device maker missed expectations for second-quarter revenue and offered weak full-year guidance for the measure. That exceeded analysts' expectations for earnings of $3.48 per share on revenue of $808 million, per LSEG. Norfolk Southern — Shares of the railroad operator gained 10% after a second-quarter earnings beat. Texas Roadhouse — The restaurant chain climbed 4.4% after second-quarter earnings topped expectations. Texas Roadhouse earned $1.79 per share, above the $1.64 per share estimate from analysts surveyed by LSEG.

Persons: Dexcom, Coursera, Newell Brands, Newell, Boston Beer, LSEG, Mohawk, Bristol Myers Squibb, Morgan Stanley, FactSet, amortization, Bitcoin, Alexander, Baldwin —, Alexander & Baldwin, Piper Sandler, Guggenheim, Sweetgreen —, Oppenheimer, Stifel, Yun Li, Pia Singh, Sean Conlon, Jesse Pound, Hakyung Kim, Lisa Kailai Han Organizations: LSEG, Newell, Yankee, Wall, Boston Beer, Boston, Mohawk Industries, Bristol Myers Squibb, Bristol, Revenue, Norfolk Southern, Norfolk, Charter Communications, Southwest Airlines, Deutsche Bank, Southwest, Redburn, FactSet, FTAI Aviation, Texas, Texas Roadhouse, LSEG . Revenue, Colgate, Palmolive Locations: Norfolk

Search resuls for: "Dexcom"

25 mentions found